Study of REGN6569 and Cemiplimab in Adult Patients with Advanced Solid Tumor Malignancies
R6569-ONC-1933
Phase 1 other active
Quick answer
Study of REGN6569 and Cemiplimab in Adult Patients with Advanced Solid Tumor Malignancies for Squamous Cell Carcinoma of Head and Neck is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Squamous Cell Carcinoma of Head and Neck
- Phase
- Phase 1
- Modality
- other
- Status
- active